vs
Pebblebrook Hotel Trust（PEB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Pebblebrook Hotel Trust的季度营收约是REPLIGEN CORP的1.7倍（$345.7M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -5.3%，领先12.0%），REPLIGEN CORP同比增速更快（13.6% vs 7.9%），Pebblebrook Hotel Trust自由现金流更多（$114.5M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -6.7%）
Pebblebrook Hotel Trust是一家公开上市的房地产投资信托，主要在美国核心城市及休闲目的地持有、运营并投资高端、奢华及精品酒店物业，服务商务与休闲旅客，聚焦高需求市场以推动长期价值增长。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PEB vs RGEN — 直观对比
营收规模更大
PEB
是对方的1.7倍
$197.9M
营收增速更快
RGEN
高出5.7%
7.9%
净利率更高
RGEN
高出12.0%
-5.3%
自由现金流更多
PEB
多$96.9M
$17.6M
两年增速更快
RGEN
近两年复合增速
-6.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $345.7M | $197.9M |
| 净利润 | $-18.4M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 2.3% | 9.0% |
| 净利率 | -5.3% | 6.7% |
| 营收同比 | 7.9% | 13.6% |
| 净利润同比 | 31.8% | 143.9% |
| 每股收益（稀释后） | $-0.26 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PEBRGEN
| Q1 26 | $345.7M | — | ||
| Q4 25 | $349.0M | $197.9M | ||
| Q3 25 | $398.7M | $188.8M | ||
| Q2 25 | $407.5M | $182.4M | ||
| Q1 25 | $320.3M | $169.2M | ||
| Q4 24 | $337.6M | $174.1M | ||
| Q3 24 | $404.5M | $154.9M | ||
| Q2 24 | $397.1M | $154.1M |
净利润PEBRGEN
| Q1 26 | $-18.4M | — | ||
| Q4 25 | $-17.9M | $13.3M | ||
| Q3 25 | $-33.1M | $14.9M | ||
| Q2 25 | $18.1M | $14.9M | ||
| Q1 25 | $-32.9M | $5.8M | ||
| Q4 24 | $-50.5M | $-30.3M | ||
| Q3 24 | $43.7M | $-654.0K | ||
| Q2 24 | $30.9M | $3.3M |
毛利率PEBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率PEBRGEN
| Q1 26 | 2.3% | — | ||
| Q4 25 | 2.5% | 9.0% | ||
| Q3 25 | -2.6% | 8.9% | ||
| Q2 25 | 12.9% | 7.6% | ||
| Q1 25 | -2.3% | 3.9% | ||
| Q4 24 | -6.7% | -17.7% | ||
| Q3 24 | 11.6% | -5.1% | ||
| Q2 24 | 15.4% | 1.0% |
净利率PEBRGEN
| Q1 26 | -5.3% | — | ||
| Q4 25 | -5.1% | 6.7% | ||
| Q3 25 | -8.3% | 7.9% | ||
| Q2 25 | 4.4% | 8.2% | ||
| Q1 25 | -10.3% | 3.4% | ||
| Q4 24 | -15.0% | -17.4% | ||
| Q3 24 | 10.8% | -0.4% | ||
| Q2 24 | 7.8% | 2.2% |
每股收益（稀释后）PEBRGEN
| Q1 26 | $-0.26 | — | ||
| Q4 25 | $-0.22 | $0.24 | ||
| Q3 25 | $-0.37 | $0.26 | ||
| Q2 25 | $0.06 | $0.26 | ||
| Q1 25 | $-0.37 | $0.10 | ||
| Q4 24 | $-0.47 | $-0.55 | ||
| Q3 24 | $0.24 | $-0.01 | ||
| Q2 24 | $0.16 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $196.2M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $2.4B | $2.1B |
| 总资产 | $5.3B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PEBRGEN
| Q1 26 | $196.2M | — | ||
| Q4 25 | $184.2M | $767.6M | ||
| Q3 25 | $223.2M | $748.7M | ||
| Q2 25 | $256.1M | $708.9M | ||
| Q1 25 | $208.1M | $697.2M | ||
| Q4 24 | $206.7M | $757.4M | ||
| Q3 24 | $134.0M | $784.0M | ||
| Q2 24 | $101.7M | $809.1M |
总债务PEBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | $542.2M | ||
| Q3 25 | $2.2B | $537.9M | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.2B | $525.6M | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.2B | — |
股东权益PEBRGEN
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.5B | $2.1B | ||
| Q3 25 | $2.5B | $2.1B | ||
| Q2 25 | $2.6B | $2.1B | ||
| Q1 25 | $2.6B | $2.0B | ||
| Q4 24 | $2.7B | $2.0B | ||
| Q3 24 | $2.8B | $2.0B | ||
| Q2 24 | $2.7B | $2.0B |
总资产PEBRGEN
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.3B | $2.9B | ||
| Q3 25 | $5.6B | $2.9B | ||
| Q2 25 | $5.7B | $2.9B | ||
| Q1 25 | $5.7B | $2.9B | ||
| Q4 24 | $5.7B | $2.8B | ||
| Q3 24 | $5.7B | $2.8B | ||
| Q2 24 | $5.7B | $2.9B |
负债/权益比PEBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.86× | 0.26× | ||
| Q3 25 | 0.89× | 0.26× | ||
| Q2 25 | 0.85× | — | ||
| Q1 25 | 0.85× | — | ||
| Q4 24 | 0.83× | 0.27× | ||
| Q3 24 | 0.80× | — | ||
| Q2 24 | 0.80× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $114.5M | $17.6M |
| 自由现金流率自由现金流/营收 | 33.1% | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流PEBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $249.7M | $25.7M | ||
| Q3 25 | $77.6M | $48.1M | ||
| Q2 25 | $90.5M | $28.6M | ||
| Q1 25 | $50.3M | $15.0M | ||
| Q4 24 | $275.0M | $39.2M | ||
| Q3 24 | $76.1M | $49.3M | ||
| Q2 24 | $83.7M | $42.2M |
自由现金流PEBRGEN
| Q1 26 | $114.5M | — | ||
| Q4 25 | $152.3M | $17.6M | ||
| Q3 25 | $6.8M | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $146.3M | $33.6M | ||
| Q3 24 | $-24.8M | $42.3M | ||
| Q2 24 | — | $37.4M |
自由现金流率PEBRGEN
| Q1 26 | 33.1% | — | ||
| Q4 25 | 43.6% | 8.9% | ||
| Q3 25 | 1.7% | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | 43.3% | 19.3% | ||
| Q3 24 | -6.1% | 27.3% | ||
| Q2 24 | — | 24.3% |
资本支出强度PEBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 27.9% | 4.1% | ||
| Q3 25 | 17.7% | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | 38.1% | 3.2% | ||
| Q3 24 | 24.9% | 4.5% | ||
| Q2 24 | — | 3.1% |
现金转化率PEBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 5.01× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.74× | — | ||
| Q2 24 | 2.70× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEB
| Room | $214.5M | 62% |
| Food and beverage | $91.1M | 26% |
| Other | $40.0M | 12% |
RGEN
暂无分部数据
